KRAS and non-small cell lung carcinoma: Luo et al. showed that ZC3H13 might bind with K‐Ras, which is frequently mutated in various cancers, such as non‐small cell lung cancer (NSCLC) and colon carcinoma 31, 32, and is tightly associated with cancer progression.